Several studies have shown that AURKA is frequently amplified in several tumors, including breast, pancreatic, colorectal, gastric, and ovarian carcinomas, and in some cases is associated with a poor prognosis26–28. This evidence concerns the gene AURKA and ovarian carcinoma.